Redx Pharma is a technology development resource for the global pharmaceutical market. Since September 2010 Redx Pharma has raised £10m in private investment and secured government and public funding grants of £11.1m. Our innovation has been validated across more than 30 different chemical classes and 11 different therapeutic areas, and we anticipate significant revenue from 2014.

Investor News

Redx Pharma opens £10.5 million R&D centre at Alderley Park
7 May 2013

Liverpool-based drug discovery and development company Redx Pharma is to open a new research and development facility at AstraZeneca's Alderley Park site in Cheshire.

The new venture, Redx Anti-Infectives Ltd, will create 119 high value science jobs at the site, establishing a new team to develop drugs combatting resistance to antibiotics and new medicines to tackle viral infections.

Read more

Contact Us

Redx Pharma is advised on corporate finance by Acceleris Ltd.